Amgen Inc. (AMGN)

253.00
4.70 1.90
NASDAQ
Prev Close 248.27
Open 247.42
Day Low/High 246.12 / 253.35
52 Wk Low/High 177.05 / 264.97
Volume 2.77M
Exchange NASDAQ
Shares Outstanding 582.17B
Market Cap 144.53B
P/E Ratio 20.01
Div & Yield N.A. (N.A)
Jim Cramer: Here's Why the Market Is Cheering Georgia's Results

Jim Cramer: Here's Why the Market Is Cheering Georgia's Results

The fears of what would happen from Democratic wins in Georgia's race failed to pan out, aside from tech taking a few hits. Here's what's happening instead and why.

Real Money Post Industrial Average Bests Most Major Indexes in 2020

Real Money Post Industrial Average Bests Most Major Indexes in 2020

As we enter the new year, there's little time to reflect on RMPIA's strong performance. Now, it's all eyes on the 12 months ahead of us.

My 10 'No Doubt' Predictions for 2021

My 10 'No Doubt' Predictions for 2021

From Amazon to Zoom, here are my prognostications and best ideas for the new year.

Amgen Rated New Buy at Daiwa

Let's See How These Dividend Gifts Stack Up

Let's See How These Dividend Gifts Stack Up

Let's compare several dividend increases in time for the holidays -- and see who wins the 'derby.'

Bearish Bets: 2 Nasdaq Stocks You Should Consider Shorting This Week

Bearish Bets: 2 Nasdaq Stocks You Should Consider Shorting This Week

These names are displaying technical deterioration.

A 3% Dividend Yield With Growth in the Pipeline

A 3% Dividend Yield With Growth in the Pipeline

With four consecutive flat quarterly dividends, this pharmaceutical name could be on the verge of another hefty raise.

Real Money Post Industrial Average Rises 21% Year to Date

Real Money Post Industrial Average Rises 21% Year to Date

The average declined in October, but it was less than that hit took by the major indexes.

Surviving in This Environment, Shaky Recovery, Lilly and Pfizer Setbacks

Surviving in This Environment, Shaky Recovery, Lilly and Pfizer Setbacks

The 'work from home' or 'economic lockdown' trade is close to being back on.

Eli Lilly Could Rally After Passing the Test

Eli Lilly Could Rally After Passing the Test

Successful tests of a rising 200-day moving average line can be great entry points for longs.

No Ordinary Month, Fear September?, Put/Call Ratio, TikTok Bidding War, Amazon

No Ordinary Month, Fear September?, Put/Call Ratio, TikTok Bidding War, Amazon

How September markets digest August ahead of momentous events will be far more important to uptrend maintenance than how August closed.

Pizza, Splits and Stocks

Apple's weight in the (price-weighted) Dow Jones Industrial Average, effective this morning, will be reduced from 12% to 3% -- based on the company's 4-1 stock split. In response to that split, Amgen , Honeywell , and Salesforce are being added to t...

Weakness in September? Dwindling Trading Volume, Fed Speak, Cybersecurity Stocks

Weakness in September? Dwindling Trading Volume, Fed Speak, Cybersecurity Stocks

September, not October, is historically the weakest month of the year for equity markets, though October has had more high profile collapses.

A Healthy Dose of Vaccine and Pharmaceutical Plays

A Healthy Dose of Vaccine and Pharmaceutical Plays

6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.

Amgen Might Be the Right Medicine for the Dow

Amgen Might Be the Right Medicine for the Dow

Let's check the charts as this biotech replaces Pfizer on the DJIA.

Jim Cramer: All These Stocks Are Not Quite 'Dow and Out'

Jim Cramer: All These Stocks Are Not Quite 'Dow and Out'

Let's look at the Dow Jones' swapping of Exxon for Salesforce, Pfizer for Amgen and Raytheon for Honeywell.

A Technical Look at the New Dow Jones Industrial Average

A Technical Look at the New Dow Jones Industrial Average

Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.

Here's Something to Try if You're Looking to Get Long Honeywell

Here's Something to Try if You're Looking to Get Long Honeywell

What I see: This stock responds well to economic recovery.

Apple Still King, Dow Shell Game, More Market Faith, Renewed China Talks?

Apple Still King, Dow Shell Game, More Market Faith, Renewed China Talks?

Monday's market action was in no way similar to that recent disparity between the 'haves' and 'have nots.'

Danger Beneath the Waves, Chip Stocks Ahoy, Fiscal Battle, Sizing Up Starbucks

Danger Beneath the Waves, Chip Stocks Ahoy, Fiscal Battle, Sizing Up Starbucks

Negotiations on the next round of stimulus, more so than tension between Washington and Beijing, and more so than earnings season, will control short-term financial market performance.

SPACs Aren't Just for Trading: 2 Attractive Buy and Hold Opportunities

SPACs Aren't Just for Trading: 2 Attractive Buy and Hold Opportunities

I like putting some of my money with incredibly successful folks who are well-connected and have a history of success.

Regeneron, PayPal, Facebook Push Up Real Money Post Industrial Average

Regeneron, PayPal, Facebook Push Up Real Money Post Industrial Average

The RMPIA rose 3.2% for May and 3.3% for the first five months of 2020.

Buffett's Great Airline Escape, Tech Leadership, ECB Wiggle Room

Buffett's Great Airline Escape, Tech Leadership, ECB Wiggle Room

Don't just follow the herd, time your exits and entrances well -- even if it is a big player like Warren Buffett that is leading the charge.

Trading Volumes Rising, GDP Forecasts, Earnings and Trading Thoughts

Trading Volumes Rising, GDP Forecasts, Earnings and Trading Thoughts

Market leadership may be lacking on Thursday despite rising trading volumes, plus an update on Apple, Microsoft, Mastercard, Amazon and Gilead.

Amgen Looks Set to Soar to New Heights - Despite the Naysayers

Amgen Looks Set to Soar to New Heights - Despite the Naysayers

Here's how to play the biotech with earnings on the horizon.

The Market Refuses to Embrace Negatives as Major Earnings Reports Roll In

The Market Refuses to Embrace Negatives as Major Earnings Reports Roll In

So far, earnings season has not been the obstacle that many have feared.

Jim Cramer: Here Are the Stocks That 'Transom' Money Is Buying

Jim Cramer: Here Are the Stocks That 'Transom' Money Is Buying

They buy and buy and buy. The same stocks. Over and over. No end to it.

Real Money Post Industrial Average Leads, but Coronavirus Adds Uncertainty

Real Money Post Industrial Average Leads, but Coronavirus Adds Uncertainty

RMPIA ended January up 0.8%, but now the damage from the Wuhan virus is weighing on the future.